IRIS
TOSCO, ANTONELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.408
NA - Nord America 1.219
EU - Europa 1.021
SA - Sud America 184
Continente sconosciuto - Info sul continente non disponibili 66
AF - Africa 41
OC - Oceania 1
Totale 3.940
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.152
SG - Singapore 607
RU - Federazione Russa 449
VN - Vietnam 343
CN - Cina 251
IT - Italia 235
BR - Brasile 145
HK - Hong Kong 86
DE - Germania 75
NL - Olanda 74
FI - Finlandia 48
FR - Francia 46
CA - Canada 43
CI - Costa d'Avorio 24
BD - Bangladesh 23
GB - Regno Unito 23
IE - Irlanda 19
MX - Messico 16
AR - Argentina 15
JP - Giappone 15
ES - Italia 11
KR - Corea 10
AT - Austria 9
EC - Ecuador 9
IQ - Iraq 8
TR - Turchia 8
UA - Ucraina 8
ID - Indonesia 7
IN - India 7
PH - Filippine 7
SK - Slovacchia (Repubblica Slovacca) 7
TH - Thailandia 7
ZA - Sudafrica 7
SE - Svezia 6
CO - Colombia 4
JO - Giordania 4
TW - Taiwan 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
KZ - Kazakistan 3
LT - Lituania 3
MA - Marocco 3
OM - Oman 3
PL - Polonia 3
PY - Paraguay 3
VE - Venezuela 3
AL - Albania 2
GT - Guatemala 2
KE - Kenya 2
PK - Pakistan 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AO - Angola 1
AU - Australia 1
BE - Belgio 1
BG - Bulgaria 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
HN - Honduras 1
IL - Israele 1
IR - Iran 1
JM - Giamaica 1
LB - Libano 1
LU - Lussemburgo 1
MG - Madagascar 1
ML - Mali 1
MN - Mongolia 1
PA - Panama 1
TN - Tunisia 1
YE - Yemen 1
Totale 3.874
Salva come PNG Salva come JPEG
Città #
Singapore 273
San Jose 194
Ashburn 121
Chandler 111
Moscow 102
Ho Chi Minh City 84
Beijing 80
Hong Kong 80
Naples 80
Hanoi 68
Amsterdam 66
Santa Clara 57
The Dalles 43
Napoli 39
Hefei 35
Munich 35
Los Angeles 31
Lauterbourg 26
New York 22
Haiphong 20
Turku 20
Da Nang 19
Millbury 18
Ottawa 17
Helsinki 15
São Paulo 15
Tokyo 15
Boston 14
Council Bluffs 14
Nanjing 13
Princeton 13
Buffalo 12
Dong Ket 12
Lawrence 11
Des Moines 10
Phoenix 10
Jacksonville 9
Montreal 9
Redondo Beach 9
Rome 9
Dallas 8
Mexico City 8
Orem 8
Biên Hòa 7
Bratislava 7
Frankfurt am Main 7
Seoul 7
Toronto 7
Bắc Giang 6
Mugnano Di Napoli 6
Ribeirão Preto 6
Houston 5
Nuremberg 5
Quito 5
Verona 5
Villaricca 5
Ankara 4
Baghdad 4
Bologna 4
Can Tho 4
Chennai 4
Hải Dương 4
Jiaxing 4
London 4
Motta di Livenza 4
Nanchang 4
Rio de Janeiro 4
Seattle 4
Stockholm 4
Tashkent 4
Thái Bình 4
Vienna 4
Aparecida de Goiânia 3
Atlanta 3
Bangkok 3
Belo Horizonte 3
Calgary 3
Caxias do Sul 3
Changsha 3
Curitiba 3
Denver 3
Dhaka 3
Fairfield 3
Falkenstein 3
Florence 3
Hebei 3
Jinan 3
Memphis 3
Peruíbe 3
Poplar 3
Queens 3
Selargius 3
Shenyang 3
Tianjin 3
Vĩnh Long 3
Wilmington 3
Wuhan 3
Zhengzhou 3
Điện Bàn 3
Abidjan 2
Totale 2.080
Salva come PNG Salva come JPEG
Nome #
TAS2R38 genotype and CRS severity in children with cystic fibrosis 177
A novel treatment of cystic fibrosis acting on-target: cysteamine plus epigallocatechin gallate for the autophagy-dependent rescue of class II-mutated CFTR 163
A complicated association between two different genetic rare disorders: Cystic Fibrosis and Spinal Muscular Atrophy 162
Intra-individual biological variation in sweat chloride concentrations in CF, CFTR dysfunction, and healthy pediatric subjects 158
Lung structure and function similarities between primary ciliary dyskinesia and mild cystic fibrosis: a pilot study 153
Cysteamine re-establishes the clearance of Pseudomonas aeruginosa by macrophages bearing the cystic fibrosis-relevant F508del-CFTR mutation 153
Serum and intestinal IGA anti-tissue transglutaminase antibodies in celiac children under 2 years of age. 147
Immunoglobulin A anti-tissue transglutaminase antibody deposits in the small intestinal mucosa of children with no villous atrophy. 143
Clinical, HLA and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. 142
Discriminant score for celiac disease based on immunohistochemical analysis of duodenal biopsies 140
Long-term benefits of nusinersen in a child affected by cystic fibrosis and spinal muscular atrophy type 1. 139
Potential celiac patients: a model of celiac disease pathogenesis. 138
Intestinal deposits of IgA anti tissue transglutaminase antibodies in celiac children under two years of age. 133
Impact of CFTR Modulators on Beta-Cell Function in Children and Young Adults with Cystic Fibrosis 130
TAS2R38 is a novel modifier gene in patients with cystic fibrosis 129
Intestinal anti-tissue transglutaminase antibodies in potential coeliac disease. 128
Methicillin-resistant Staphylococcus aureus eradication in cystic fibrosis patients: A randomized multicenter study 127
Diabetes outbreak during COVID19 lock-down in a prediabetic patient with cystic fibrosis long treated with glargine. 127
A survey of the prevalence, management and outcome of infants with an inconclusive diagnosis following newborn bloodspot screening for cystic fibrosis (CRMS/CFSPID) in six Italian centres. 124
Non-invasive tools for detection of liver disease in children and adolescents with cystic fibrosis. 124
Intestinal titres of anti-tissue transglutaminase 2 antibodies correlate positively with mucosal damage degree and inversely with gluten-free diet duration in celiac disease. 121
Elevated sweat chloride test: is it always cystic fibrosis 121
NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity 120
Glucose Tolerance Stages in Cystic Fibrosis Are Identified by a Unique Pattern of Defects of Beta-Cell Function. 109
Manipulating proteostasis to repair the F508del-CFTR defect in cystic fibrosis 107
Clinical outcomes of a large cohort of individuals with the F508del/5T;TG12 CFTR genotype 92
Crellastatin A, a PARP-1 Inhibitor Discovered by Complementary Proteomic Approaches 90
Clinical outcome of individuals carrying 5T;TG12 in trans with CFTR variants with varying clinical consequences 72
Hemoglobin Levels in Children Treated for Cystic Fibrosis with CFTR Modulators: A Single Center Retrospective Study 59
Blood platelet reduction after elexacaftor/tezacaftor/ivacaftor treatment in people with cystic fibrosis may depend on systemic inflammation reduction 58
A Longitudinal Study of Glucose Tolerance in Cystic Fibrosis: The Central Role of Beta Cell Functional Mass 56
Efficacy of Elexacaftor/Tezacaftor/Ivacaftor in a Cystic Fibrosis Child With L1077P Mutation 32
Cystic fibrosis: New insights into therapeutic approaches 30
Repurposing therapies for the personalised treatment of cystic fibrosis 23
Mutation-specific therapies and drug repositioning in cystic fibrosis 13
Totale 3.940
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.399
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.399
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022158 0 0 5 0 1 23 11 1 18 10 41 48
2022/2023309 24 9 9 13 47 32 0 36 75 50 11 3
2023/2024206 5 25 55 17 7 23 4 24 0 6 26 14
2024/2025995 46 63 2 9 48 45 77 77 67 78 389 94
2025/20261.997 185 180 190 176 363 70 190 121 304 116 48 54
2026/202752 45 7 0 0 0 0 0 0 0 0 0 0
Totale 3.940